Overview

A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted

Status:
Completed

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to determine if oxycodone and naltrexone combination capsules (ALO-02) have the potential to be abused when they are crushed and snorted.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Collaborators:

INC Research
Syneos Health

Treatments:

Analgesics, Opioid
Naltrexone
Oxycodone